Arrowhead Pharmaceuticals, Inc.(ARWR)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
ARWR | 10.47 B | -32.73x | -86.40% | -48.38% | $-2.27 | -42.37% | 2.31 | - | $84.55 | $14.30 |
MDGL | 12.76 B | -41.06x | 1.27% | -27.32% | $-13.48 | -49.35% | 0.64 | - | $615.00 | $284.02 |
BMRN | 11.52 B | 42.87x | 2.80% | 8.29% | $1.39 | 4.48% | 0.23 | - | $66.28 | $49.26 |
SMMT | 10.72 B | -8.69x | - | - | $-1.59 | -2.71% | 3.67 | - | $30.98 | $12.55 |
IONS | 8.99 B | -27.06x | 87.00% | -30.90% | $-2.01 | -67.62% | 5.31 | - | $86.74 | $39.72 |
Peer Valuation & Performance Analysis
Peer group analysis for Arrowhead Pharmaceuticals, Inc. (ARWR) compared to its primary competitors (including MDGL, BMRN, SMMT) reveals distinct metrics. ARWR trades at a valuation discount relative to its competitors, with a P/E ratio of -32.7x versus the peer average of -8.5x (representing a 286% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, ARWR's revenue growth of -86.4% lags behind the peer average of 30.4%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -48.4% is below the peer average of -16.6%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• ARWR ranks #0 in P/E ratio, #5 in revenue growth, and #5 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $70.92 | $74.80 | $70.01 | $74.30 | 3,775,200 | +4.77% |
| 2026-07-16 | $70.92 | $73.00 | $69.95 | $71.38 | 2,578,700 | +0.64% |
| 2026-07-15 | $71.91 | $72.67 | $69.89 | $71.82 | 1,863,669 | -0.13% |
| 2026-07-14 | $74.42 | $75.33 | $71.81 | $71.91 | 1,635,700 | -3.37% |
| 2026-07-13 | $74.82 | $74.89 | $72.66 | $74.11 | 2,480,000 | -0.95% |
| 2026-07-10 | $84.48 | $84.48 | $76.18 | $76.40 | 2,952,100 | -9.56% |
| 2026-07-09 | $86.12 | $87.73 | $83.30 | $84.00 | 1,437,600 | -2.46% |
| 2026-07-08 | $85.87 | $86.86 | $84.19 | $85.74 | 1,660,400 | -0.15% |
| 2026-07-07 | $87.28 | $87.57 | $83.79 | $86.97 | 1,914,800 | -0.35% |
| 2026-07-06 | $84.59 | $87.83 | $83.13 | $86.55 | 2,445,200 | +2.32% |
| 2026-07-02 | $81.14 | $83.99 | $79.92 | $83.99 | 1,703,400 | +3.51% |
| 2026-07-01 | $82.28 | $82.39 | $78.81 | $80.44 | 1,975,600 | -2.24% |
| 2026-06-30 | $80.52 | $84.06 | $78.86 | $81.51 | 2,715,400 | +1.23% |
| 2026-06-29 | $79.79 | $80.59 | $78.17 | $80.50 | 1,656,600 | +0.89% |
| 2026-06-26 | $78.94 | $82.30 | $77.45 | $78.89 | 18,919,800 | -0.06% |